No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / surgery
-
Chemotherapy, Adjuvant
-
Disease-Free Survival
-
Female
-
France
-
Humans
-
Middle Aged
-
Receptor, ErbB-2 / metabolism
-
Retrospective Studies
-
Trastuzumab
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Receptor, ErbB-2
-
Trastuzumab